-
Materials (Basel, Switzerland) May 2020The paper describes the mechanical behavior of fine recycled concrete aggregate (FRCA) concrete according to the mineral admixtures. Three types of the mineral...
The paper describes the mechanical behavior of fine recycled concrete aggregate (FRCA) concrete according to the mineral admixtures. Three types of the mineral admixtures, i.e., fly ash (FA), ground-granulated blast-furnace slag (GGBS), and silica fume (SF), are used and the replacement ratios of FRCA are 50% and 100%. The dosages of the admixtures of FA, GGBS, and SF are determined with the normal dosage (30%, 40%, and 5.0%, respectively) based on the ACI committee reports (No. 232, 233, and 234) and half-normal dosage. The mechanical performance is investigated with the compressive and splitting tensile strength, and elastic modulus. Additionally, the total porosity is measured in natural fine aggregate (NFA) and FRCA 100% replaced specimens by mercury intrusion porosimetry (MIP) for investigating the relationship with the compressive strength. Based on the experimental test results, the mineral admixtures improve the mechanical performance of FRCA concrete. The effective dosages of FA, GGBS, and SF for FRCA concrete are investigated according to the replacement ratio of the FRCA. In particular, FRCA 100% replaced concrete may be possible to be used for the structural concrete members with the specific dosage of the mineral admixtures. The prediction of the splitting tensile strength and the elastic modulus by the codes or previous formulas exhibits underestimated and overestimated results, respectively. The relationship between the total porosity and the compressive strength of the FRCA concrete should be modified with more experimental tests.
PubMed: 32423034
DOI: 10.3390/ma13102264 -
The Western Journal of Emergency... Apr 2017We sought to develop evidence-based recommendations for the prehospital evaluation and treatment of adult and pediatric patients with a seizure and to compare these...
INTRODUCTION
We sought to develop evidence-based recommendations for the prehospital evaluation and treatment of adult and pediatric patients with a seizure and to compare these recommendations against the current protocol used by the 33 emergency medical services (EMS) agencies in California.
METHODS
We performed a review of the evidence in the prehospital treatment of patients with a seizure, and then compared the seizure protocols of each of the 33 EMS agencies for consistency with these recommendations. We analyzed the type and route of medication administered, number of additional rescue doses permitted, and requirements for glucose testing prior to medication. The treatment for eclampsia and seizures in pediatric patients were analyzed separately.
RESULTS
Protocols across EMS Agencies in California varied widely. We identified multiple drugs, dosages, routes of administration, re-dosing instructions, and requirement for blood glucose testing prior to medication delivery. Blood glucose testing prior to benzodiazepine administration is required by 61% (20/33) of agencies for adult patients and 76% (25/33) for pediatric patients. All agencies have protocols for giving intramuscular benzodiazepines and 76% (25/33) have protocols for intranasal benzodiazepines. Intramuscular midazolam dosages ranged from 2 to 10 mg per single adult dose, 2 to 8 mg per single pediatric dose, and 0.1 to 0.2 mg/kg as a weight-based dose. Intranasal midazolam dosages ranged from 2 to 10 mg per single adult or pediatric dose, and 0.1 to 0.2 mg/kg as a weight-based dose. Intravenous/intrasosseous midazolam dosages ranged from 1 to 6 mg per single adult dose, 1 to 5 mg per single pediatric dose, and 0.05 to 0.1 mg/kg as a weight-based dose. Eclampsia is specifically addressed by 85% (28/33) of agencies. Forty-two percent (14/33) have a protocol for administering magnesium sulfate, with intravenous dosages ranging from 2 to 6 mg, and 58% (19/33) allow benzodiazepines to be administered.
CONCLUSION
Protocols for a patient with a seizure, including eclampsia and febrile seizures, vary widely across California. These recommendations for the prehospital diagnosis and treatment of seizures may be useful for EMS medical directors tasked with creating and revising these protocols.
Topics: Administration, Intranasal; Administration, Intravenous; Adult; Anticonvulsants; Benzodiazepines; California; Child; Clinical Protocols; Eclampsia; Emergency Medical Services; Evidence-Based Practice; Female; Humans; Magnesium Sulfate; Male; Midazolam; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Seizures, Febrile; Status Epilepticus
PubMed: 28435493
DOI: 10.5811/westjem.2016.12.32066 -
Journal of Thoracic Disease Jun 2013To explore the feasibility and dosage of tramadol combined with fentanyl in awake endotracheal intubation.
OBJECTIVE
To explore the feasibility and dosage of tramadol combined with fentanyl in awake endotracheal intubation.
METHODS
Using Dixon's up-and-down sequential design, the study enrolled patients from each of the 20-49, 50-60 and 70-and-above age groups scheduled for elective surgery under general anesthesia. The feasibility and dosage of tramadol combined with fentanyl in awake endotracheal intubation, guided by fiberoptic bronchoscopy, were verified.
RESULTS
After intravenous injection with fentanyl 2.2 μg/kg and tramadol 2.0 mg/kg in the 20-49 age group, fentanyl 1.6 μg/kg and tramadol 1.9 mg/kg in the 50-69 age group and fentanyl 1 μg/kg and tramadol 1.8 mg/kg in those at the age of 70 or above, the patients achieved conscious sedation without obvious respiratory depression. Meanwhile, under these dosages, the patients could easily tolerate the thyrocricocentesis airway surface anesthesia and fiberoptic bronchoscope guided tracheal intubation. Postoperative follow-up showed that most patients had memory of the intubation process but without significant discomfort. No awake endotracheal intubation-related side effect was noted.
CONCLUSIONS
Fiberoptic bronchoscope guided nasotracheal intubation can be successfully completed with background administration of fentanyl and tramadol. However, the specific dosages need to be tailored in different age of patients.
PubMed: 23825758
DOI: 10.3978/j.issn.2072-1439.2013.03.10 -
Poultry Science Jul 2021The present study investigated the dosage and replication effects of lipopolysaccharide challenges on the serum oxidative and immune status, and the intestinal...
The present study investigated the dosage and replication effects of lipopolysaccharide challenges on the serum oxidative and immune status, and the intestinal morphology and permeability of Linwu ducks at the growing stage. A total of 500 54-day-old Linwu ducks were randomly assigned into 10 treatments, which included a factorial arrangement of 2 levels of LPS challenge replications (1 and 2 times) × 5 levels of lipopolysaccharide challenging dosages (0, 0.1, 0.2, 0.4, and 0.8 mg/kg). Each treatment consisted of 5 cages and 10 ducks per cage. The results showed significant replication effects of LPS on the body weight gain of ducks, that 2 replicates of LPS challenges significantly decreased the body weight gain than one challenge (P = 0.036). Regarding to the serum oxidative and immune status, dosage effects of lipopolysaccharide were found on the serum levels of superoxide dismutase (P = 0.034) and immunoglobulin A (P = 0.007), that 0.4 mg/kg lipopolysaccharides significantly increased the levels of these 2 parameters. Additionally, replication effects were found in the serum levels of interlukin 1β, that 2 replicates of LPS challenges significantly increased the interlukin 1β levels comparing to one challenge (P = 0.010). Regarding to the intestinal conditions, dosage effects of lipopolysaccharides were found on the ratio of villus height and crypt depth (P = 0.005) in duodenum, and the wall thickness of duodenum (P = 0.010) and jejunum (P = 0.001), that lipopolysaccharides at 0.1, 0.2, and 0.8 mg/kg significantly deteriorated the intestinal morphologies, especially in the duodenum and jejunum. Moreover, the dosage effects of lipopolysaccharides and the interactions of dosages and replications significantly influenced the permeabilities of the intestinal segments (P < 0.05). It appeared that 2 replicates of lipopolysaccharides at the dosage at 0.4 mg/kg could trigger oxidative and immunological stress, and damage the intestinal morphology and permeability of Linwu ducks at the growing stage.
Topics: Animals; Antioxidants; Chickens; Diet; Dietary Supplements; Ducks; Lipopolysaccharides
PubMed: 34116351
DOI: 10.1016/j.psj.2021.101199 -
Cancer Chemotherapy and Pharmacology Oct 2008Calcitriol potentiates cisplatin-mediated activity in a variety of tumor models. We examine here, the effect of calcitriol and cisplatin pre-clinically and clinically in...
PURPOSE
Calcitriol potentiates cisplatin-mediated activity in a variety of tumor models. We examine here, the effect of calcitriol and cisplatin pre-clinically and clinically in canine spontaneous tumors through in vitro studies on tumor cells and through a phase I study of calcitriol and cisplatin to identify the maximum-tolerated dosage (MTD) of this combination in dogs with cancer and to characterize the pharmacokinetic disposition of calcitriol in dogs.
METHODS
Canine tumor cells were investigated for calcitriol/cisplatin interactions on proliferation using an MTT assay in a median-dose effect analysis; data were used to derive a combination index (CI). Cisplatin was given at a fixed dosage of 60 mg/m2. Calcitriol was given i.v. and the dosage was escalated in cohorts of three dogs until the MTD was defined. Serum calcitriol concentrations were quantified by radioimmunoassay.
RESULTS
In vitro, CIs < 1.0 were obtained for all combinations of calcitriol/cisplatin examined. The MTD was 3.75 microg/kg calcitriol in combination with cisplatin, and hypercalcemia was the dose-limiting toxicosis. The relationship between calcitriol dosage and either Cmax or AUC was linear. Calcitriol dosages >1.5 microg/kg achieved Cmax > or = 9.8 ng/mL and dosages >1.0 microg/kg achieved AUC > or = 45 h ng/mL.
CONCLUSIONS
Calcitriol and cisplatin have synergistic antiproliferative effects on multiple canine tumor cells and high-dosages of i.v. calcitriol in combination with cisplatin can be safely administered to dogs. Cmax and AUC at the MTD 3.75 microg/kg calcitriol exceed concentrations associated with antitumor activity in a murine model, indicating this combination might have significant clinical utility in dogs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Calcitriol; Cell Line, Tumor; Cisplatin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Hypersensitivity; Gastrointestinal Diseases; Hematologic Diseases; Injections, Intravenous; Neoplasms; Tetrazolium Salts; Thiazoles; Vitamins
PubMed: 18246349
DOI: 10.1007/s00280-008-0678-x -
Revue Medicale de Liege Nov 2005Oral administration of lithium is used as treatment in psychiatry. The drug frequently induces cutaneous side effects corresponding to acneiform or maculo-papular... (Review)
Review
Oral administration of lithium is used as treatment in psychiatry. The drug frequently induces cutaneous side effects corresponding to acneiform or maculo-papular eruptions, psoriasis and folliculitis. Men are more frequently affected than women. These manifestations are characterized by the accumulation of neutrophils in the skin. Alopecia and classical drug reactions are also possible. Topical applications of lithium used to treat some dermatoses do not induce similar side effects, probably because dosages are much lower.
Topics: Administration, Oral; Administration, Topical; Antimanic Agents; Drug Eruptions; Humans; Lithium Carbonate; Sex Factors; Skin Diseases
PubMed: 16402535
DOI: No ID Found -
Journal of Veterinary Internal Medicine 2011Pharmacodynamic assays measure the immunosuppressive effects of cyclosporine on T-cells and offer an alternative assessment of efficacy in individual patients. (Clinical Trial)
Clinical Trial
BACKGROUND
Pharmacodynamic assays measure the immunosuppressive effects of cyclosporine on T-cells and offer an alternative assessment of efficacy in individual patients.
OBJECTIVE
To assess the immunosuppressive effects of high and low dosage cyclosporine on canine T-cells and to develop a novel testing system for individualized dose adjustment.
ANIMALS
Seven healthy female Walker hounds.
METHODS
Experimental study using a paired comparison design. Flow cytometry was used to measure T-cell expression of IL-2, IL-4, and IFN-γ. Cytokine expression 8 days after oral administration of high and low dosages of cyclosporine was compared to baseline and washout values, respectively. The high dosage was initially 10 mg/kg q12h and was then adjusted to attain established immunosuppressive trough blood drug concentrations (>600 ng/mL). The low dosage was 5 mg/kg q24h.
RESULTS
High dosage cyclosporine resulted in significant decreases in IL-2 and IFN-γ expression (P = .0156, P = .0156), but not IL-4 expression (P = .2188). Low dosage cyclosporine was associated with a significant decrease in IFN-γ expression (P = .0156), while IL-2 expression was not affected (P = .1094).
CONCLUSIONS AND CLINICAL IMPORTANCE
T-cell function is suppressed at trough blood drug concentrations exceeding 600 ng/mL, and is at least partially suppressed in some dogs at low dosages. Direct evaluation of T-cell function could be an effective, more sensitive alternative to measuring blood drug concentrations for monitoring immunosuppressive therapy.
Topics: Administration, Oral; Animals; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; T-Lymphocytes
PubMed: 22092633
DOI: 10.1111/j.1939-1676.2011.00797.x -
Bulletin of the World Health... 1960It is well known that in the treatment of tuberculosis with isoniazid the complication of peripheral neuritis may arise. This complication is normally rare when small...
It is well known that in the treatment of tuberculosis with isoniazid the complication of peripheral neuritis may arise. This complication is normally rare when small dosages of the drug are used, but a high incidence of the neuropathy has recently been observed in East Africa in a group of malnourished tuberculous patients receiving isoniazid in comparatively low dosage (4-6 mg/kg body-weight daily). The present paper reports on 20 cases of peripheral neuritis encountered in Madras, India, among 338 poorly nourished tuberculous patients during a trial of four isoniazid regimens, two of low and two of high dosage (3.9-5.5 and 7.8-9.6 mg/kg body-weight daily, respectively). Nineteen of the 20 cases occurred in the two groups of patients receiving the high dosage and these 19 patients were found to have a higher mean serum level of free isoniazid than the patients in the same groups who did not develop the complication. The authors consider that dosages of 7.8-9.6 mg/kg body-weight daily should not be used for the mass therapy of poorly nourished patients unless steps are taken to prevent the development of peripheral neuritis. Pyridoxine has been reported to be an effective preventive, but is too expensive for use on a large scale. This study indicates, however, that administration of the cheaper vitamin B complex might give satisfactory results and warrants further investigation.
Topics: Africa, Eastern; Folic Acid; Humans; India; Isoniazid; Neuritis; Peripheral Nervous System Diseases; Pyridoxine; Tuberculosis; Vitamin B Complex
PubMed: 13722334
DOI: No ID Found -
Plants (Basel, Switzerland) Dec 2022In this study, sheep manure fertilizers with different dosages were used for five consecutive years to treat acidified tea plantation soils, and the effects of sheep...
In this study, sheep manure fertilizers with different dosages were used for five consecutive years to treat acidified tea plantation soils, and the effects of sheep manure fertilizer on soil pH value, nitrogen transformation, and tea yield and quality were analyzed. The results showed that soil pH value showed an increasing trend after a continuous use of sheep manure fertilizer from 2018 to 2022. After the use of low dosage of sheep manure fertilizer (6 t/hm-15 t/hm), tea yield, the content of tea quality indicators (tea polyphenols, theanine, amino acid, and caffeine) and soil ammonium nitrogen content, ammoniating bacteria number, ammoniating intensity, urease activity and protease activity showed increasing trends and were significantly and positively correlated to soil pH value, while the related indexes showed increasing and then decreasing trends after the use of high dosage of sheep manure fertilizer (18 t/hm). Secondly, the nitrate nitrogen content, nitrifying bacteria number, nitrifying intensity, nitrate reductase activity, and nitrite reductase activity showed decreasing trends after the use of low dosage of sheep manure fertilizer and showed significant negative correlations with soil pH value, while the related indexes showed decreasing trends after the use of high dosage of sheep manure and then increased. The results of principal component and interaction analysis showed that the effects of sheep manure fertilizers with different dosages on tea yield and quality were mainly based on the transformation ability of ammonium nitrogen and nitrate nitrogen in the soil, and the strong transformation ability of ammonium nitrogen and the high ammonium nitrogen content in the soil were conducive to the improvement of tea yield and quality, and vice versa. The results of topsis comprehensive evaluation and analysis showed that the most influential effect on the fertilization effect was the ammonium nitrogen content in the soil and long-term treatment with 15 t/hm of sheep manure fertilizer had the highest proximity to the best fertilization effect. This study provided an important practical basis for the remediation and fertilizer management in acidified tea plantation soils.
PubMed: 36616251
DOI: 10.3390/plants12010122 -
Anesthesia and Analgesia May 2016Tumescent lidocaine anesthesia consists of subcutaneous injection of relatively large volumes (up to 4 L or more) of dilute lidocaine (≤1 g/L) and epinephrine (≤1...
BACKGROUND
Tumescent lidocaine anesthesia consists of subcutaneous injection of relatively large volumes (up to 4 L or more) of dilute lidocaine (≤1 g/L) and epinephrine (≤1 mg/L). Although tumescent lidocaine anesthesia is used for an increasing variety of surgical procedures, the maximum safe dosage is unknown. Our primary aim in this study was to measure serum lidocaine concentrations after subcutaneous administration of tumescent lidocaine with and without liposuction. Our hypotheses were that even with large doses (i.e., >30 mg/kg), serum lidocaine concentrations would be below levels associated with mild toxicity and that the concentration-time profile would be lower after liposuction than without liposuction.
METHODS
Volunteers participated in 1 to 2 infiltration studies without liposuction and then one study with tumescent liposuction totally by local anesthesia. Serum lidocaine concentrations were measured at 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, and 24 hours after each tumescent lidocaine infiltration. Area under the curve (AUC∞) of the serum lidocaine concentration-time profiles and peak serum lidocaine concentrations (Cmax) were determined with and without liposuction. For any given milligram per kilogram dosage, the probability that Cmax >6 μg/mL, the threshold for mild lidocaine toxicity was estimated using tolerance interval analysis.
RESULTS
In 41 tumescent infiltration procedures among 14 volunteer subjects, tumescent lidocaine dosages ranged from 19.2 to 52 mg/kg. Measured serum lidocaine concentrations were all <6 μg/mL over the 24-hour study period. AUC∞s with liposuction were significantly less than those without liposuction (P = 0.001). The estimated risk of lidocaine toxicity without liposuction at a dose of 28 mg/kg and with liposuction at a dose of 45 mg/kg was ≤1 per 2000.
CONCLUSIONS
Preliminary estimates for maximum safe dosages of tumescent lidocaine are 28 mg/kg without liposuction and 45 mg/kg with liposuction. As a result of delayed systemic absorption, these dosages yield serum lidocaine concentrations below levels associated with mild toxicity and are a nonsignificant risk of harm to patients.
Topics: Adrenergic Agonists; Anesthesia, Local; Anesthetics, Local; Area Under Curve; California; Drug Combinations; Drug Monitoring; Epinephrine; Heart Rate; Humans; Injections, Subcutaneous; Lidocaine; Lipectomy; Metabolic Clearance Rate; Patient Safety; Risk Assessment
PubMed: 26895001
DOI: 10.1213/ANE.0000000000001119